日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages.

与奥沙利铂联合使用可通过重组肿瘤内巨噬细胞来改善溶瘤病毒疗法的远隔效应

Tomita Kyoko, Yamashita Midori, Ikegami Kentaro, Shimizu Yoshiko, Amino Nobuaki, Nakao Shinsuke

A Multiple-Model-Informed Drug-Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

基于多模型指导的溶瘤病毒联合帕博利珠单抗最佳治疗方案选择药物开发方法

Yamada, Akihiro; Choules, Mary P; Brightman, Frances A; Takeshita, Shigeru; Nakao, Shinsuke; Amino, Nobuaki; Nakayama, Takeshi; Takeuchi, Masato; Komatsu, Kanji; Ortega, Fernando; Mistry, Hitesh; Orrell, David; Chassagnole, Christophe; Bonate, Peter L

Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice

中和单克隆抗体可改善静脉注射溶瘤腺病毒在人CD46转基因小鼠体内的生物分布。

Hemmi, Masahisa; Yamashita, Midori; Shimizu, Yoshiko; Nakao, Shinsuke

Oncolytic vaccinia virus induces a novel phenotype of CD8(+) effector T cells characterized by high ICOS expression.

溶瘤痘苗病毒诱导了一种新型的 CD8(+)效应T细胞表型,其特征是ICOS高表达

Yamashita Midori, Tasaki Mamoru, Murakami Ryuji, Arai Yukinori, Nakamura Takafumi, Nakao Shinsuke